Following Trulieve's Blockbuster Earnings, Curaleaf Followed Suit with an Impressive Quarter of its Own, Which Featured Strong Revenue Growth and a Dramatically Reduced Net Loss As a Result, Analysts Have... read more →
Trulieve Crushed Wall Street's Expectations After Posting Q2 2020 Revenue and Adjusted EBITDA of $120.8 Million and $60.5 Million, Respectively In Addition to Trulieve's Stellar Second Quarter Earnings, the Company... read more →
Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of May 25th – 31st, 2020.... read more →
Top U.S. MSO Trulieve Posted 2019 Total Revenue of $252.8 Million, Up 145% Year-Over-Year Despite the Coronavirus Crisis, Trulieve Reaffirmed its Financial Guidance for 2020 Trulieve (CSE: TRUL) (OTCQX: TCNNF)... read more →
The Two Top Cannabis Markets Go Head-to-Head U.S. or Canadian Cannabis Stocks, Which Group Currently Offers Investors the Most Value? After the cannabis sector ended the week on a high... read more →
Cantor Fitzgerald Analyst Pablo Zuanic Sees "Green Days Ahead" for Canadian Pot Stocks New 264-Page Research Note Features Ratings and Price Targets on 6 of Canada's Top Cannabis Stocks Cantor... read more →
